I am not a licensed financial advisor. This is a documented public experiment, not investment advice. Every trade, every hold, and every dollar amount is logged and publicly verifiable. See the pre-registration post for the full rules of this experiment.
This is Day 2 of the Investing Smarter Test — a 12-month experiment where I gave an AI $1,000 in a real Robinhood account and let it trade on its own. The only question I’m trying to answer: can an AI beat the simplest thing a person could do with $1,000, which is drop it in an S&P 500 index fund and walk away?
This morning, the AI made its second move: it bought XBI — the SPDR S&P 500 Biotech ETF — while the broader market sold off. Here’s where things stand.
The Daily Money Brief — Free, at 10 AM
Money you may be owed, scams to dodge, and the fine print decoded — the consumer money news that affects your wallet, every weekday.
Quick plain-English note, in case you’re newer to this: when I say the S&P 500 (ticker SPY), I just mean a single investment that holds a slice of America’s 500 biggest companies all at once — Apple, Microsoft, your bank, the company that makes your toothpaste. You buy one thing and you instantly own a little piece of all of them. That’s the “boring index fund” everyone keeps telling you to buy — and it’s the yardstick the AI has to beat. Learn that one term and you’re already ahead of most people.
What This Does NOT Prove
Before I show you the scoreboard, a word about what you’re looking at.
This is one account. One run. One AI. Twelve months. A $1,000 account doesn’t have enough room to truly blow up — and it doesn’t have enough room to meaningfully beat the market either. Statistics require sample sizes. One experiment is a story, not a proof.
If the AI is up right now, that doesn’t prove AI investing works. If it’s down, that doesn’t prove it can’t. What it does prove is whether this specific AI, following this specific strategy, beat or lost to the simplest available alternative — a plain index fund — over this particular stretch of time.
I’m publishing every day, win or lose. If the AI blows up, you’ll see it here. That’s the point.
The Investing Smarter Test Scoreboard — Day 2 (June 23, 2026)
| AI Account | S&P 500 Index (Benchmark) | |
|---|---|---|
| Starting value | $1,000.00 | $1,000.00 |
| Current value | $995.58 | $987.21 |
| Change from start | −$4.42 (−0.44%) | −$12.79 (−1.28%) |
| AI vs. Index gap | +$8.37 ahead | — |
| Max drawdown (AI) | −0.46% | −1.41% |
The S&P 500 benchmark: $1,000 invested in SPY on June 22, 2026 (the experiment start date), dividends reinvested, no fees. The honest comparison is always “what would $1,000 in an index fund have done?”
Two days in, the AI account is down $4.42 — but SPY is down $12.79 on the same market day. The AI is ahead by $8.37. Worth a caution while it’s early: this is a tiny account over two days, and a lead this small is almost certainly noise, not signal — I wouldn’t read anything into it yet, in either direction.
If This Were $10,000 Instead of $1,000
| If you’d started with $10,000 | AI Account | S&P 500 Index |
|---|---|---|
| Starting value | $10,000.00 | $10,000.00 |
| Current value | $9,955.80 | $9,872.12 |
| Change from start | −$44.20 (−0.44%) | −$127.88 (−1.28%) |
| AI vs. Index gap | +$83.68 ahead | — |
The point of showing both isn’t “look what the AI could have made you.” It’s the gap. At $1,000 the AI is ahead of the boring index fund by $8.37; scaled to $10,000 that same gap is $83.68 — same story, bigger numbers. Whether it’s $1,000 or $10,000, the question is identical: did the clever thing beat the boring index fund? — and notice the boring index fund’s number scales just as cleanly without anyone having to watch it every day. (This is illustrative scaling of a tiny two-day sample — not a projection, not a promise.)
What the AI Did Today
The AI made a trade this morning. Here’s exactly what happened:
Action: BUY
Security: XBI — SPDR S&P Biotech ETF
Shares: 1.010237
Price: $148.48
Total: $150.00
Account cash remaining: $749.00
Account invested: ~$246.49 (VWO $96.87 + XBI $148.64 + AAPL $0.99)
The AI’s Logged Reasoning
Here is the AI’s rationale, logged at the time of the decision. I’m publishing it verbatim:
XBI broke to a new 52-week high today ($148.75) on strong volume (16.7M vs 10M avg), confirming the 6-month uptrend from $121 in December. This is a clean trend breakout, not hype — price action is the signal. Fundamental catalyst: biotech M&A on pace for best year since pre-Covid per CNBC ($106B YTD across 201 deals). Sector ETF diversifies single-stock risk. Current holdings reviewed: AAPL ($1 position, near highs, HOLD); VWO ($97, -2.66%, post-ex-div pullback from high, thesis intact, HOLD).
Again: this rationale is confident. It’s supposed to be — the AI is built to generate coherent explanations. A confident rationale is not proof that the trade is correct. We’ll find out over time.
What would kill this thesis, per the AI’s own log: Close below $142 (prior resistance turned support) on 2 consecutive days, OR sector-wide negative catalyst (FDA policy shift, major deal collapse), OR the 50-day moving average crossing below the 200-day moving average.
How This Fits the Strategy
The AI is following a documented strategy. This trade fits that strategy in the sense that XBI hit a new 52-week high with strong volume — a clean technical breakout the AI was looking for. The position is sized at about 15% of the account, consistent with its diversification mandate.
Risk profile of this trade:
- Position size: ~15% of the account
- Asset type: Sector ETF (Biotech)
- Volatility: Medium-High (biotech sector swings with FDA news and deal flow)
- Drawdown risk: A major FDA rejection or deal collapse could push XBI back toward $142 support. Below that, the AI has committed to reassessing.
Also held: a second AI “gang” shadow panel ran a projected consensus this morning and favored holding cash over adding EWJ (Japan). The solo AI (the live decider) disagreed and bought XBI instead. Both decisions are logged.
What You Should Actually Do With $1,000
I get this question every time I write about investing experiments: “Should I do what the AI is doing?”
Here’s my honest answer: probably not.
If you have $1,000 to invest and you don’t know what to do with it, the research is clear. Put it in a low-cost S&P 500 index fund — something like SPY, VOO, or FSKAX. Set it up as automatic monthly contributions if you can. Don’t check it daily.
Where to actually do it. Here are some of the most common places people start, and what each is best for. A note on the links, because I want to be straight with you: for each one I give you two links — a referral link and a plain direct link. If you use my referral link, you and I both get a small bonus or some free money from the company. If you’d rather not, use the plain link and I get nothing — it makes no difference to me, and the choice is always yours. I’d never ask you to use mine. (You can read my full promise of independence here.)
- Vanguard — the low-cost gold standard. Buy VOO (their S&P 500 fund) directly; fees are about 0.03% a year. Best if you’re comfortable setting it up yourself and want the cheapest option, period. Vanguard has no referral program, so there’s just one link: vanguard.com.
- Betterment — a robo-advisor that builds and rebalances an index portfolio for you automatically. Best if you’d rather not think about it at all. You pay roughly 0.25% a year on top of fund fees for that convenience. → referral link (we both get a bonus) or plain link (I get nothing).
- Acorns — rounds up your spare change and invests it. Best for building the habit of investing with small amounts. → referral link ($5 for you after you invest, plus a bonus for me) or plain link (I get nothing).
- Robinhood — the same commission-free broker this very experiment runs on. Fine for buying VOO or SPY and leaving it alone (just don’t get pulled into day-trading). → referral link (you get a free fractional share, $5–$200 in value, and I get one too) or plain link (I get nothing).
That’s it. That’s the boring, reliable thing. The entire point of this experiment is to find out whether a sophisticated AI can actually beat that boring, reliable thing — and after 2 days, here’s exactly where it stands: the AI is $8.37 ahead of the index fund, on a day when the market went down. We’re a long way from knowing whether that’s skill or just two days of luck.
Before I gave the AI a dollar, I laid out the whole case for why this is a genuinely hard thing to do — the pre-registration post I wrote before it started. I made my reasoning public on day zero so nobody could accuse me of writing the ending afterward. Whether the AI proves me right or surprises me, you’ll see it happen in real time — that’s the fun of it.
Transparency: The Full Log Is Public
Every trade this AI has made or declined to make — plus its logged reasoning — is documented in an append-only, timestamped reasoning log. The AI’s decision for today was logged before the order was placed. If you want to verify anything in this post, the log is the source of truth.
FAQ
Q: How is the S&P 500 benchmark calculated?
A: I recorded the price of SPY on June 22, 2026, the same day the AI account placed its first real trade. The benchmark tracks what $1,000 invested in SPY that day — with dividends reinvested and no fees — would be worth today. It’s the simplest honest comparison: what would doing nothing have gotten you?
Q: Can I follow along or copy the AI’s trades?
A: You can follow along — every trade and hold decision is logged. I’d encourage you NOT to copy the trades, though. This is one $1,000 experiment, not a recommendation — a single concentrated account isn’t a sound way for anyone to invest their own money, no matter how it ends up doing. The better move is the boring one above: a low-cost index fund, left alone.
Q: Why did the AI buy XBI specifically?
A: The AI identified XBI hitting a new 52-week high on above-average volume as a trend-confirmation signal, backed by a concrete fundamental catalyst (record biotech M&A activity in 2026). It passed on other candidates — Japan ETF (EWJ), for example — that it judged as “pretty good, not excellent.” The full rationale is logged and quoted above.
